# Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive

> **NCT01963403** · PHASE4 · TERMINATED · sponsor: **University of California, Davis** · enrollment: 26 (actual)

## Conditions studied

- Abnormal Uterine Bleeding, Unspecified
- Uterine Bleeding Heavy

## Interventions

- **DRUG:** EE 30mcg/LNG 150mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01963403
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2015-07
- **Final completion:** 2015-09
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Futility of recruitment
- **Last updated:** 2017-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01963403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01963403, "Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01963403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*